학술논문
Cardiovascular safety of rapidly accelerated fibrosarcoma B-type and/or mitogen-activated extracellular signal-regulated kinase inhibitors: A mixed approach combining a meta-analysis and a pharmacovigilance disproportionality analysis
Document Type
Article
Author
Source
In Archives of Cardiovascular Diseases June-July 2020 113(6-7):420-432
Subject
Language
ISSN
1875-2136